<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; Socioeconomic</title>
	<atom:link href="http://www.tapanray.in/tag/socioeconomic/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Blockchain: A Game Changer For Safe Medicines</title>
		<link>http://www.tapanray.in/blockchain-a-game-changer-for-safe-medicines/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=blockchain-a-game-changer-for-safe-medicines</link>
		<comments>http://www.tapanray.in/blockchain-a-game-changer-for-safe-medicines/#comments</comments>
		<pubDate>Mon, 09 Jul 2018 00:00:02 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Africa]]></category>
		<category><![CDATA[anti-counterfeit]]></category>
		<category><![CDATA[Blockchain]]></category>
		<category><![CDATA[Changer]]></category>
		<category><![CDATA[combating]]></category>
		<category><![CDATA[Counterfeit]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[DTAB]]></category>
		<category><![CDATA[economic]]></category>
		<category><![CDATA[Fake]]></category>
		<category><![CDATA[Game]]></category>
		<category><![CDATA[Genentech]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[IMPACT]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[measures]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[menace]]></category>
		<category><![CDATA[Niti]]></category>
		<category><![CDATA[Niti Aayog]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[safe]]></category>
		<category><![CDATA[Socioeconomic]]></category>
		<category><![CDATA[Spurious]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[technology]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9049</guid>
		<description><![CDATA[‘Your medicine box may have fake drugs’ was the March 18, 2018 headline of a popular pan Indian news daily. Just the year before, the 2017 report of the World Health Organization (WHO), also flagged that around 10.5 percent of all medicines in &#8230; <a href="http://www.tapanray.in/blockchain-a-game-changer-for-safe-medicines/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/blockchain-a-game-changer-for-safe-medicines/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Why MNC Pharma Still Moans Over Indian IP Ecosystem?</title>
		<link>http://www.tapanray.in/why-mnc-pharma-still-moans-over-indian-ip-ecosystem/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=why-mnc-pharma-still-moans-over-indian-ip-ecosystem</link>
		<comments>http://www.tapanray.in/why-mnc-pharma-still-moans-over-indian-ip-ecosystem/#comments</comments>
		<pubDate>Mon, 14 May 2018 00:00:03 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[2018]]></category>
		<category><![CDATA[3.d]]></category>
		<category><![CDATA[301]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Bank]]></category>
		<category><![CDATA[Chamber]]></category>
		<category><![CDATA[Cheaper]]></category>
		<category><![CDATA[CL]]></category>
		<category><![CDATA[Commerce]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[competition]]></category>
		<category><![CDATA[Compulsory]]></category>
		<category><![CDATA[concerns]]></category>
		<category><![CDATA[data]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[ecosystem]]></category>
		<category><![CDATA[expensive]]></category>
		<category><![CDATA[Form 27]]></category>
		<category><![CDATA[generics]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[Index]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Intellectual]]></category>
		<category><![CDATA[IP]]></category>
		<category><![CDATA[License]]></category>
		<category><![CDATA[manufacturing]]></category>
		<category><![CDATA[market]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[MNC]]></category>
		<category><![CDATA[Moon]]></category>
		<category><![CDATA[multi]]></category>
		<category><![CDATA[National]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[PhRMA]]></category>
		<category><![CDATA[Policy]]></category>
		<category><![CDATA[Property]]></category>
		<category><![CDATA[Protection]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[Report]]></category>
		<category><![CDATA[Socioeconomic]]></category>
		<category><![CDATA[Special]]></category>
		<category><![CDATA[TADF]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[UN]]></category>
		<category><![CDATA[US]]></category>
		<category><![CDATA[USTR]]></category>
		<category><![CDATA[working]]></category>
		<category><![CDATA[WTO]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9004</guid>
		<description><![CDATA[Improving patient access to expensive drugs, paving the way for entry of their cheaper generic equivalents, post patent expiry, and avoiding evergreening, is assuming priority a priority focus area in many countries. The United States is no exception, in this &#8230; <a href="http://www.tapanray.in/why-mnc-pharma-still-moans-over-indian-ip-ecosystem/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/why-mnc-pharma-still-moans-over-indian-ip-ecosystem/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>‘Digiceuticals’: A Force Multiplier to Contain Chronic Diseases</title>
		<link>http://www.tapanray.in/digiceuticals-a-force-multiplier-to-contain-chronic-diseases/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=digiceuticals-a-force-multiplier-to-contain-chronic-diseases</link>
		<comments>http://www.tapanray.in/digiceuticals-a-force-multiplier-to-contain-chronic-diseases/#comments</comments>
		<pubDate>Sun, 22 Oct 2017 23:30:15 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[app]]></category>
		<category><![CDATA[chronic]]></category>
		<category><![CDATA[consumer]]></category>
		<category><![CDATA[diabetes]]></category>
		<category><![CDATA[digiceuticals]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[disorders]]></category>
		<category><![CDATA[epidemic]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[NCD]]></category>
		<category><![CDATA[pull]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[smartphone]]></category>
		<category><![CDATA[Socioeconomic]]></category>
		<category><![CDATA[suppliers]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[Therapeutics]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=8373</guid>
		<description><![CDATA[There is a growing need for more effective prevention, treatment or management of many serious Noninfectious Chronic Diseases (NCDs), with greater safety and at a lesser cost. As a major step in this direction, ‘digiceuticals’ or ‘digital therapeutics’ are now &#8230; <a href="http://www.tapanray.in/digiceuticals-a-force-multiplier-to-contain-chronic-diseases/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/digiceuticals-a-force-multiplier-to-contain-chronic-diseases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The ‘Moonshot&#8217;: Access To World-Class Cancer Care, For All</title>
		<link>http://www.tapanray.in/the-moonshot-access-to-world-class-cancer-care-for-all/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-moonshot-access-to-world-class-cancer-care-for-all</link>
		<comments>http://www.tapanray.in/the-moonshot-access-to-world-class-cancer-care-for-all/#comments</comments>
		<pubDate>Mon, 08 Feb 2016 00:00:48 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[All]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[bank. WHO]]></category>
		<category><![CDATA[Barack]]></category>
		<category><![CDATA[Biden]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[class]]></category>
		<category><![CDATA[democracy]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Joe]]></category>
		<category><![CDATA[Lancet]]></category>
		<category><![CDATA[largest]]></category>
		<category><![CDATA[Moonshot]]></category>
		<category><![CDATA[Obama]]></category>
		<category><![CDATA[oldest]]></category>
		<category><![CDATA[oncology]]></category>
		<category><![CDATA[President]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Socioeconomic]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[Vice-President]]></category>
		<category><![CDATA[World]]></category>
		<category><![CDATA[world’s]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=7438</guid>
		<description><![CDATA[As in every year, February the 4th was celebrated as the ‘World Cancer Day’, across the world, in 2016, as well. Its main objective is to commemorate all the efforts done by the World Health Organization (WHO), the United Nations &#8230; <a href="http://www.tapanray.in/the-moonshot-access-to-world-class-cancer-care-for-all/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-moonshot-access-to-world-class-cancer-care-for-all/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>With Highest Billionaire Wealth Concentration, India Tops Malnutrition Chart in South Asia: &#8220;What Future Do You Want?&#8221;</title>
		<link>http://www.tapanray.in/with-highest-billionaire-wealth-concentration-india-tops-malnutrition-chart-in-south-asia-what-future-do-you-want/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=with-highest-billionaire-wealth-concentration-india-tops-malnutrition-chart-in-south-asia-what-future-do-you-want</link>
		<comments>http://www.tapanray.in/with-highest-billionaire-wealth-concentration-india-tops-malnutrition-chart-in-south-asia-what-future-do-you-want/#comments</comments>
		<pubDate>Mon, 26 Jan 2015 00:00:15 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Amit]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[Bank]]></category>
		<category><![CDATA[Bill]]></category>
		<category><![CDATA[Billionaire]]></category>
		<category><![CDATA[BJP]]></category>
		<category><![CDATA[Chart]]></category>
		<category><![CDATA[Concentration]]></category>
		<category><![CDATA[Court]]></category>
		<category><![CDATA[Davos]]></category>
		<category><![CDATA[demographic]]></category>
		<category><![CDATA[dividend]]></category>
		<category><![CDATA[Gates]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[highest]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[inequality]]></category>
		<category><![CDATA[Justice Louis Brandeis]]></category>
		<category><![CDATA[Malnutrition]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[National]]></category>
		<category><![CDATA[oxfam]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Policy]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Report]]></category>
		<category><![CDATA[Shah]]></category>
		<category><![CDATA[Social]]></category>
		<category><![CDATA[Socioeconomic]]></category>
		<category><![CDATA[South]]></category>
		<category><![CDATA[Supreme]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tops]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[UNICEF]]></category>
		<category><![CDATA[US]]></category>
		<category><![CDATA[Wealth]]></category>
		<category><![CDATA[WEF]]></category>
		<category><![CDATA[What Future Do You Want]]></category>
		<category><![CDATA[World]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=6352</guid>
		<description><![CDATA[Two recent global research reports, though on different spheres, place India at the top of the respective blocks. However, the take away messages that the studies offer are indeed poles apart in qualitative terms and worth pondering over collectively. On &#8230; <a href="http://www.tapanray.in/with-highest-billionaire-wealth-concentration-india-tops-malnutrition-chart-in-south-asia-what-future-do-you-want/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/with-highest-billionaire-wealth-concentration-india-tops-malnutrition-chart-in-south-asia-what-future-do-you-want/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Does the Landmark Glivec Judgment Discourage Innovation in India?</title>
		<link>http://www.tapanray.in/does-the-landmark-glivec-judgment-discourage-innovation-in-india/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=does-the-landmark-glivec-judgment-discourage-innovation-in-india</link>
		<comments>http://www.tapanray.in/does-the-landmark-glivec-judgment-discourage-innovation-in-india/#comments</comments>
		<pubDate>Mon, 08 Apr 2013 00:00:19 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[191]]></category>
		<category><![CDATA[2005]]></category>
		<category><![CDATA[3d]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[AstraZeneca]]></category>
		<category><![CDATA[Case]]></category>
		<category><![CDATA[Challenges]]></category>
		<category><![CDATA[Cipal]]></category>
		<category><![CDATA[commission]]></category>
		<category><![CDATA[Court]]></category>
		<category><![CDATA[Delhi]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[efficacy]]></category>
		<category><![CDATA[gefitinib. Roche]]></category>
		<category><![CDATA[Glenmark]]></category>
		<category><![CDATA[Glivec]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[highcourt]]></category>
		<category><![CDATA[incremental]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[innovative]]></category>
		<category><![CDATA[Innovators]]></category>
		<category><![CDATA[interpretation]]></category>
		<category><![CDATA[IPA]]></category>
		<category><![CDATA[IPO]]></category>
		<category><![CDATA[IPR]]></category>
		<category><![CDATA[Janumet]]></category>
		<category><![CDATA[Januvia]]></category>
		<category><![CDATA[Judgment]]></category>
		<category><![CDATA[knowledge]]></category>
		<category><![CDATA[landmark]]></category>
		<category><![CDATA[medicines. imatinib]]></category>
		<category><![CDATA[mesylate]]></category>
		<category><![CDATA[MSD]]></category>
		<category><![CDATA[Natco]]></category>
		<category><![CDATA[National]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[organization]]></category>
		<category><![CDATA[out]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[patentability]]></category>
		<category><![CDATA[pegasys]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[revocation]]></category>
		<category><![CDATA[section]]></category>
		<category><![CDATA[Socioeconomic]]></category>
		<category><![CDATA[step]]></category>
		<category><![CDATA[stutent]]></category>
		<category><![CDATA[Supreme]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[therapeutic]]></category>
		<category><![CDATA[time]]></category>
		<category><![CDATA[TRIPS]]></category>
		<category><![CDATA[WHO]]></category>
		<category><![CDATA[with]]></category>
		<category><![CDATA[wockhardt]]></category>
		<category><![CDATA[World]]></category>
		<category><![CDATA[Zita]]></category>
		<category><![CDATA[Zita-Met]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=2150</guid>
		<description><![CDATA[No, I do not think so. The 112 pages well articulated judgment of the Supreme Court of India delivered on April 1, 2013, does not even remotely discourage innovation in India, including much talked about ‘incremental innovation’. This landmark judgment &#8230; <a href="http://www.tapanray.in/does-the-landmark-glivec-judgment-discourage-innovation-in-india/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/does-the-landmark-glivec-judgment-discourage-innovation-in-india/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>India &#8211; Young Today, Old Tomorrow: Emerging Issues of Aging, Health and Socioeconomic Profile of the Country</title>
		<link>http://www.tapanray.in/india-young-today-old-tomorrow-emerging-issues-of-aging-health-and-socioeconomic-profile-of-the-country/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=india-young-today-old-tomorrow-emerging-issues-of-aging-health-and-socioeconomic-profile-of-the-country</link>
		<comments>http://www.tapanray.in/india-young-today-old-tomorrow-emerging-issues-of-aging-health-and-socioeconomic-profile-of-the-country/#comments</comments>
		<pubDate>Sun, 29 Apr 2012 01:30:13 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Aging]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[Country]]></category>
		<category><![CDATA[emerging]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Issues]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Old]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Profile]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Socioeconomic]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[Today]]></category>
		<category><![CDATA[Tomorrow]]></category>
		<category><![CDATA[WHO]]></category>
		<category><![CDATA[Young]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=100</guid>
		<description><![CDATA[‘World Health Day’ is celebrated every year on April 7, the day ‘World Health Organization (WHO)’ was founded in 1948. Each year, on this day, people from all walks of life across the globe are invited by WHO to focus &#8230; <a href="http://www.tapanray.in/india-young-today-old-tomorrow-emerging-issues-of-aging-health-and-socioeconomic-profile-of-the-country/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/india-young-today-old-tomorrow-emerging-issues-of-aging-health-and-socioeconomic-profile-of-the-country/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Path-breaking medicines are just not enough… a comprehensive healthcare reform in India is long overdue</title>
		<link>http://www.tapanray.in/path-breaking-medicines-are-just-not-enough-a-comprehensive-healthcare-reform-in-india-is-long-overdue/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=path-breaking-medicines-are-just-not-enough-a-comprehensive-healthcare-reform-in-india-is-long-overdue</link>
		<comments>http://www.tapanray.in/path-breaking-medicines-are-just-not-enough-a-comprehensive-healthcare-reform-in-india-is-long-overdue/#comments</comments>
		<pubDate>Mon, 14 Jun 2010 00:30:49 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[are]]></category>
		<category><![CDATA[breaking]]></category>
		<category><![CDATA[comprehensive]]></category>
		<category><![CDATA[enough]]></category>
		<category><![CDATA[equity]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[inequalities]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[IPR]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[just]]></category>
		<category><![CDATA[long]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[Not]]></category>
		<category><![CDATA[outcome]]></category>
		<category><![CDATA[overdue]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[path]]></category>
		<category><![CDATA[Path-breaking]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Reform]]></category>
		<category><![CDATA[Socioeconomic]]></category>
		<category><![CDATA[Tapan]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=415</guid>
		<description><![CDATA[The Prime Minister of India, Dr. Manmohan Singh reiterated the following in his speech at the 30th Convocation of PGIMER, Chandigarh on November 3, 2009: ”As in economics, so as in medicine too, it is easy to get lost in &#8230; <a href="http://www.tapanray.in/path-breaking-medicines-are-just-not-enough-a-comprehensive-healthcare-reform-in-india-is-long-overdue/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/path-breaking-medicines-are-just-not-enough-a-comprehensive-healthcare-reform-in-india-is-long-overdue/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Are common patients in India just as the pawns of the game of chess or the victims of circumstances or both, in the socio-economic milieu of the country?</title>
		<link>http://www.tapanray.in/are-common-patients-in-india-just-as-the-pawns-of-the-game-of-chess-or-the-victims-of-circumstances-or-both-in-the-socio-economic-milieu-of-the-country/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=are-common-patients-in-india-just-as-the-pawns-of-the-game-of-chess-or-the-victims-of-circumstances-or-both-in-the-socio-economic-milieu-of-the-country</link>
		<comments>http://www.tapanray.in/are-common-patients-in-india-just-as-the-pawns-of-the-game-of-chess-or-the-victims-of-circumstances-or-both-in-the-socio-economic-milieu-of-the-country/#comments</comments>
		<pubDate>Mon, 18 Jan 2010 00:30:38 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[are]]></category>
		<category><![CDATA[as]]></category>
		<category><![CDATA[both]]></category>
		<category><![CDATA[centric]]></category>
		<category><![CDATA[chess]]></category>
		<category><![CDATA[circumstances]]></category>
		<category><![CDATA[common]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[Country]]></category>
		<category><![CDATA[delivery]]></category>
		<category><![CDATA[Game]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[high]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[infrastructure]]></category>
		<category><![CDATA[just]]></category>
		<category><![CDATA[milieu]]></category>
		<category><![CDATA[MNC]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[or]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[pawns]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Socioeconomic]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[victims]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=482</guid>
		<description><![CDATA[“Public healthcare in India has the power to deliver improved health outcomes, as demonstrated by a growing number of national and international examples. However, supportive policies need to be put in place in order to change traditional determinants of health,”said &#8230; <a href="http://www.tapanray.in/are-common-patients-in-india-just-as-the-pawns-of-the-game-of-chess-or-the-victims-of-circumstances-or-both-in-the-socio-economic-milieu-of-the-country/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/are-common-patients-in-india-just-as-the-pawns-of-the-game-of-chess-or-the-victims-of-circumstances-or-both-in-the-socio-economic-milieu-of-the-country/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Healthcare reform process and policy measures to reduce socio-economic inequalities should be implemented in tandem for optimal economic progress of a nation.</title>
		<link>http://www.tapanray.in/healthcare-reform-process-and-policy-measures-to-reduce-socio-economic-inequalities-should-be-implemented-in-tandem-for-optimal-economic-progress-of-a-nation/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=healthcare-reform-process-and-policy-measures-to-reduce-socio-economic-inequalities-should-be-implemented-in-tandem-for-optimal-economic-progress-of-a-nation</link>
		<comments>http://www.tapanray.in/healthcare-reform-process-and-policy-measures-to-reduce-socio-economic-inequalities-should-be-implemented-in-tandem-for-optimal-economic-progress-of-a-nation/#comments</comments>
		<pubDate>Thu, 24 Sep 2009 00:30:12 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[be]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[economic]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[implemented]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[inequalities]]></category>
		<category><![CDATA[measures]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[nation]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[optimal]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Policy]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[process]]></category>
		<category><![CDATA[Progress]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[reduce]]></category>
		<category><![CDATA[Reform]]></category>
		<category><![CDATA[Should]]></category>
		<category><![CDATA[Socioeconomic]]></category>
		<category><![CDATA[tandem]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[to]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=771</guid>
		<description><![CDATA[Important research studies indicate that health of an individual is as much an integral function of the related socio-economic factors as it is influenced by the person’s life style and genomic configurations.It has now been well established that socio-economic disparities &#8230; <a href="http://www.tapanray.in/healthcare-reform-process-and-policy-measures-to-reduce-socio-economic-inequalities-should-be-implemented-in-tandem-for-optimal-economic-progress-of-a-nation/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/healthcare-reform-process-and-policy-measures-to-reduce-socio-economic-inequalities-should-be-implemented-in-tandem-for-optimal-economic-progress-of-a-nation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
